Turinabol – Genetix Pharma
Product Overview
Turinabol by Genetix Pharma is a chlorodehydromethyltestosterone-based oral anabolic androgenic compound commonly known as Oral Turinabol or Tbol. Originally developed in the 1960s, it is recognized for its anabolic properties combined with relatively lower androgenic activity compared to several other compounds in its class.
Manufactured by Genetix Pharma, this product is produced under pharmaceutical-grade standards to ensure controlled dosing, consistency, and quality control.
Across performance and hormone-related discussions in the United States—including cities such as San Diego, Austin, Denver, Portland, Orlando, Columbus, Nashville, Sacramento, and Minneapolis—Turinabol is frequently referenced for its “dry” anabolic characteristics and structured use in physique-focused contexts.
Key Features
- Contains chlorodehydromethyltestosterone (Turinabol active ingredient)
- Manufactured by Genetix Pharma
- Oral anabolic androgenic steroid formulation
- Non-aromatizing compound (does not convert to estrogen)
- Pharmaceutical-grade manufacturing standards
- Known for a “dry” anabolic profile
How Turinabol Works
Turinabol works by binding to androgen receptors and influencing protein synthesis and nitrogen retention within the body. It is a modified derivative of Dianabol, originally engineered to reduce estrogenic activity and water retention.
Because it does not aromatize, it is often described as having a “dry” anabolic profile, which is commonly referenced in physique and conditioning discussions.




Reviews
There are no reviews yet.